Thromboelastography profiles for controlled circulatory death donors: Validating the role of heparin

W. Christian Crannell, Mitch Sally, Kenneth (John) McConnell, Chris Connelly, Erin Maynard, Elizabeth Dewey, Peter Abt, C. Kristian Enestvedt

Research output: Contribution to journalArticlepeer-review

Abstract

Controlled donation after circulatory death (cDCD) liver transplants are associated with increased ischemic-type biliary complications. Microvascular thrombosis secondary to decreased donor fibrinolysis may contribute to bile duct injury. We hypothesized that cDCD donors are hypercoagulable with impaired fibrinolysis and aim to use thromboelastography to characterize cDCD coagulation profiles.

Original languageEnglish (US)
Article numbere14518
JournalClinical Transplantation
Volume36
Issue number2
DOIs
StatePublished - Feb 2022

ASJC Scopus subject areas

  • Transplantation

Fingerprint

Dive into the research topics of 'Thromboelastography profiles for controlled circulatory death donors: Validating the role of heparin'. Together they form a unique fingerprint.

Cite this